Sanofi SA at Bank of America Merrill Lynch Global Healthcare Conference Transcript
(technical difficulty)
Essentially, I think, it address some of the changes that were needed in the pipeline at the time and before that, he's running the discovery business at Roche out of Basel. So John's got a few slides to go through and just a high-level intro, and then we'll be able to dig straight into Q&A.
And so John, if you'd like to maybe take the podium for the presentation.
Sure. Thanks, Graham. Well, thanks for joining today and like just to provide a bit of a brief overview of some of the ways we're currently attempting to evolve the Sanofi R&D enterprise.
Of course, you have the forward-looking statements [probably].
So really been trying to reshape the agenda for research in a couple of different ways. We, working with the team, looked at where we were as an organization, we saw that we still had some distance
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

